-+ 0.00%
-+ 0.00%
-+ 0.00%

Zhongguancun (000931.SZ): Clinical trial application for lidocaine tinocaine cream drug approved

Zhitongcaijing·07/21/2026 08:25:03
Listen to the news

Zhitong Finance App News, Zhongguancun (000931.SZ) issued an announcement. Beijing Huasu Pharmaceutical Co., Ltd. (hereinafter referred to as Beijing Huasu), a subsidiary of the company, recently received the approval and issuance of lidocaine tincaine cream (Specification: 15g: lidocaine 1,050 mg and butcaine 1,050 mg; 30g: lidocaine 2,100 mg and dicaine 2,1002,100 mg) “Drug Clinical Trial Approval Notice”.